Maravai LifeSciences Announces September 2021 Investor Conference Schedule
September 07 2021 - 7:00AM
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of
life science reagents and services to researchers and biotech
innovators, is scheduled to participate in the following virtual
investor conferences during the month of September.
On September 13, 2021, Carl Hull, Chief Executive Officer will
participate in a fireside chat at the Morgan Stanley Healthcare
Conference at 12:30 p.m. PT.
On September 14, 2021, Kevin Herde, Chief Financial
Officer, will present at the Baird Global Healthcare Conference
at 9:50 a.m. PT.
A live webcast of the presentations will be available to all
interested parties on the Maravai Lifesciences investor relations
website at http://investors.maravai.com. An archived version
of the webcast will be available a few hours following the
completion of each event on the Maravai investor relations
website.
About Maravai Maravai is a leading life
sciences company providing critical products to enable the
development of drug therapies, diagnostics, novel vaccines and to
support research on human diseases. Maravai’s companies are leaders
in providing products and services in the fields of nucleic acid
synthesis and biologic safety testing to many of the world's
leading biopharmaceutical, vaccine, diagnostics, and cell and gene
therapy companies.
For more information about Maravai LifeSciences, visit
www.maravai.com.
Contact Information:
Media Contact: Sara Michelmore
MacDougall
+1 781-235-3060
maravai@macbiocom.com
Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Sep 2023 to Sep 2024